Alternative therapies in health and medicine · 2025
Clinical Efficacy of Leech Therapy (Ta'līq al-'Alaq) in Eczema (Nār Fārsī): An Open-Label Single-Arm Clinical Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ulla P Basha Sadhik, Aaisha Bibi, Bokhari Sjb, Zabiulla P, Alam Md Anzar, Nikhat Sadia
Аннотация
BACKGROUND: Eczema, known as Nār Fārsī in Unani medicine, is a chronic skin disorder characterized by intense pruritus, dryness, and scaling of skin, along with periodic flares and remissions. Unani literature recognizes it as a disorder caused by safrāwī (bilious) humor. Conventional treatment relies on emollients, humectants, and anti-inflammatory drugs. Unani medicine recommends the expulsion of morbid matter by local blood-letting or oral therapies. Leech therapy, used in many traditional medicine systems for centuries, is a method of expulsion of morbid humors from a disease site. It is prescribed for diseases of joints, skin, the nervous system, etc. Contemporary research has identified many bioactive enzymes and proteins in leech saliva that have anti-inflammatory, analgesic, vasodilatory, antimicrobial, and many other effects.
PRIMARY STUDY OBJECTIVE: This study aimed to assess the efficacy and safety of leech therapy in eczema patients based on standard parameters.
METHODS: An open-label, single-arm clinical study was conducted on 20 patients diagnosed with eczema.
INTERVENTION: Four sessions of leech therapy were carried out with a one-week gap in between.
PRIMARY OUTCOME MEASURES: The effectiveness of leech therapy was assessed using the Eczema Area and Severity Index (EASI) Score.
RESULTS: Statistically significant improvement was observed in the severity of eczema, as reflected in the EASI Score parameters, i.e., redness (P = .0001), edema (P = .0001), excoriation (P = .0022), and lichenification (P = .0001). However, the decrease in total area involved was not statistically significant (P = .24).
CONCLUSION: Leech therapy was found to be safe and effective in relieving the severity of eczema. All patients expressed satisfaction with the treatment, without any drop-outs, indicating excellent adherence to the therapy. With further research, leech therapy may provide positive outcomes in eczema in clinical settings, providing relief to the suffering patients.
PRIMARY STUDY OBJECTIVE: This study aimed to assess the efficacy and safety of leech therapy in eczema patients based on standard parameters.
METHODS: An open-label, single-arm clinical study was conducted on 20 patients diagnosed with eczema.
INTERVENTION: Four sessions of leech therapy were carried out with a one-week gap in between.
PRIMARY OUTCOME MEASURES: The effectiveness of leech therapy was assessed using the Eczema Area and Severity Index (EASI) Score.
RESULTS: Statistically significant improvement was observed in the severity of eczema, as reflected in the EASI Score parameters, i.e., redness (P = .0001), edema (P = .0001), excoriation (P = .0022), and lichenification (P = .0001). However, the decrease in total area involved was not statistically significant (P = .24).
CONCLUSION: Leech therapy was found to be safe and effective in relieving the severity of eczema. All patients expressed satisfaction with the treatment, without any drop-outs, indicating excellent adherence to the therapy. With further research, leech therapy may provide positive outcomes in eczema in clinical settings, providing relief to the suffering patients.